Metlife Inc

NYSE: MET
$71.11
+$1.16 (+1.7%)
Closing price April 19, 2024
MetLife, Inc. is a global financial services giant offering a broad range of insurance and financial products, including life, dental, and disability insurance, along with annuities and employee benefits. It caters to both individuals and businesses, providing solutions like pension risk transfers, structured settlements, and various investment products. Founded in 1999 and headquartered in New York, MetLife operates across multiple continents, addressing the diverse needs of customers in Asia, Latin America, Europe, the Middle East, and Africa with its comprehensive portfolio.
Here are 30 stocks with sustainable dividends for income investors to consider in their portfolios.
China had a lot more to lose than the United States in the trade war over tariffs and policies. That is still true, but U.S. companies are feeling the burn too.
The top analyst upgrades, downgrades and initiations seen on Tuesday included AFL, Agilent, Allergan, Barrick Gold, Cognex, Hilton, Lloyds, MetLife, Slack and Wingstop.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Boeing, Booking, Camping World, Domino's Pizza, iRobot, MetLife, Neogen, Southern Copper, Vertex Pharmaceuticals and...
The top analyst upgrades, downgrades and initiations seen on Tuesday included BHP, Cisco Systems, Crown Castle, Gilead Sciences, Goldcorp, Take-Two Interactive Software, Varonis Systems and Whiting...
It has been a while since there has been much great to say about the banking and financial sector leaders. That said, the woes of the big banks might not pertain to some of the key non-bank...
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apache, Caesars Entertainment, Dell Technologies, Devon Energy, Hewlett Packard Enterprise, NetApp, Nordstrom, MetLife...
Investors have been finding it harder to generate positive returns in 2018, but Credit Suisse has refreshed its list of Top Picks and implied upside of 50% or more.
Regulus Therapeutics, MagneGas, MiMedx, and MetLife all posted new 52-week lows Friday.
The top analyst upgrades, downgrades and other research calls from Monday include AXA Equitable, Dollar General, Five Below, Macy's, SM Energy, Trade Desk and Whirlpool.
The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Broadcom, Caterpillar, Cree, GrubHub, Intel, 3M, MetLife and Verizon.
The top analyst upgrades, downgrades and other research calls from Wednesday include AK Steel, Apple, Biogen, Electronic Arts, FitBit, Foot Locker, McDonald's and Pfizer.
Tuesday was a down day for the U.S. markets, and in fact the worst day that we’ve seen in a long time. This is also the second consecutive day for the markets pulling back. Crude oil continued to...
Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that could radically change how Wall Street and Main Street evaluate companies ahead.
24/7 Wall St. wanted to evaluate how the Wall Street analysts were valuing Brighthouse Financial after its spin-off from MetLife.